Roche Holding AG (RHHBY)
32.81
+0.16
(+0.49%)
USD |
OTCM |
May 17, 16:00
Roche Revenue (Annual): 67.31B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 67.31B |
| December 31, 2022 | 69.01B |
| December 31, 2021 | 68.71B |
| December 31, 2020 | 62.21B |
| December 31, 2019 | 61.87B |
| December 31, 2018 | 58.11B |
| December 31, 2017 | 54.11B |
| December 31, 2016 | 51.34B |
| December 31, 2015 | 50.03B |
| December 31, 2014 | 51.93B |
| December 31, 2013 | 50.48B |
| December 31, 2012 | 48.53B |
| December 31, 2011 | 48.14B |
| Date | Value |
|---|---|
| December 31, 2010 | 45.35B |
| December 31, 2009 | 45.31B |
| December 31, 2008 | 42.23B |
| December 31, 2007 | 38.47B |
| December 31, 2006 | 33.58B |
| December 31, 2005 | 28.54B |
| December 31, 2004 | 23.80B |
| December 31, 2003 | 23.22B |
| December 31, 2002 | 18.99B |
| December 31, 2001 | 17.30B |
| December 31, 2000 | 16.99B |
| December 31, 1999 | 18.37B |
| December 31, 1998 | 17.05B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
61.87B
Minimum
2019
69.01B
Maximum
2022
65.82B
Average
67.31B
Median
2023
Revenue (Annual) Benchmarks
| Novartis AG | 46.66B |
| Pfizer Inc | 58.50B |
| ADC Therapeutics SA | 69.56M |
| Lonza Group Ltd | 7.480B |
| Sarepta Therapeutics Inc | 1.243B |